Income Statement Resverlogix Corp.

Stocks

RVX

CA76128M1086

Biotechnology & Medical Research

Market Closed - Toronto S.E. 01:16:52 05/09/2026 am IST			5-day change	1st Jan Change
0.0950 ^CAD	-5.00%		0.00%	-5.00%

14/08	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
26/06	Resverlogix Corp. - Shareholder/Analyst Call

86388b1.BsSoybPTDN0Z74WSg-PJd3arCOXhd5Nwdjv_KiSBV0k.S53lofLqZKoroNT96dq8JyySUYTXL9AdJlC4ZkDHGi1z9Jz84-J9iXCj0A

Published financial data: RESVERLOGIX CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Selling General & Admin Expenses, Total	1.14Cr	72.05L	30.17L	17.95L	19.6L
R&D Expenses	45.49L	42.29L	21.61L	28.05L	29.49L
Other Operating Expenses, Total	1.59Cr	1.14Cr	51.78L	46L	49.09L
Operating Income	-1.59Cr	-1.14Cr	-51.78L	-46L	-49.09L
Interest Expense, Total	-7L	-16.37L	-18.07L	-31.16L	-42L
Net Interest Expenses	-7L	-16.37L	-18.07L	-31.16L	-42L
Currency Exchange Gains (Loss)	-81T	29T	-19T	51T	-45T
Other Non Operating Income (Expenses)	47.3L	33.6L	7L	6L	-1L
EBT, Excl. Unusual Items	-1.2Cr	-96.82L	-62.83L	-71.01L	-92.64L
Asset Writedown	-	-12.78L	-10.29L	-	-2L
Other Unusual Items	-1.28Cr	73.68L	-94.14L	-5L	16.63L
EBT, Incl. Unusual Items	-2.48Cr	-35.92L	-1.67Cr	-76.21L	-77.56L
Income Tax Expense	12T	18T	15T	14T	11T
Earnings From Continuing Operations	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Net Income to Company	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Net Income - (IS)	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Net Income to Common Incl Extra Items	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Net Income to Common Excl. Extra Items	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Per Share Items
Net EPS - Basic	-0.1	-0.01	-0.06	-0.03	-0.03
Basic EPS - Continuing Operations	-0.1	-0.01	-0.06	-0.03	-0.03
Basic Weighted Average Shares Outstanding	24Cr	27Cr	27Cr	28Cr	29Cr
Net EPS - Diluted	-0.1	-0.01	-0.06	-0.03	-0.03
Diluted EPS - Continuing Operations	-0.1	-0.01	-0.06	-0.03	-0.03
Diluted Weighted Average Shares Outstanding	24Cr	27Cr	27Cr	28Cr	29Cr
Normalized Basic EPS	-0.03	-0.02	-0.01	-0.02	-0.02
Normalized Diluted EPS	-0.03	-0.02	-0.01	-0.02	-0.02
Supplemental Items
EBITDA	-1.55Cr	-1.1Cr	-48.22L	-42.52L	-44.79L
EBITA	-1.56Cr	-1.1Cr	-48.88L	-42.52L	-44.79L
EBIT	-1.59Cr	-1.14Cr	-51.78L	-46L	-49.09L
Effective Tax Rate - (Ratio)	-0.05	-0.5	-0.09	-0.18	-0.14
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	12T	18T	15T	14T	11T
Normalized Net Income	-74.95L	-60.51L	-39.27L	-44.38L	-57.9L
Interest on Long-Term Debt	8L	16.4L	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	17.95L	19.6L
Research And Development Expense From Footnotes	46.23L	56.16L	32.47L	28.55L	31.54L
Stock-Based Comp., R&D Exp. (Total)	8L	7L	3L	-	40T
Stock-Based Comp., G&A Exp. (Total)	-	-	-	3L	4L
Stock-Based Comp., SG&A Exp. (Total)	18.39L	16.87L	9L	-	-
Total Stock-Based Compensation	26.22L	23.92L	12.49L	3L	5L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	6T	40T	5T	99T	1L
Total Cash And Short Term Investments	6T	40T	5T	99T	1L
Other Receivables	3L	3L	58T	2L	9L
Total Receivables	3L	3L	58T	2L	9L
Inventory	24.53L	23.71L	3L	10L	4L
Prepaid Expenses	2L	1L	1L	2L	1L
Other Current Assets, Total	17T	8T	6T	40T	31T
Total Current Assets	29.53L	28.88L	5L	15.38L	16.06L
Gross Property Plant And Equipment	37.86L	27.67L	10.04L	-	-
Accumulated Depreciation	-27.47L	-23.41L	-10.04L	-	-
Net Property Plant And Equipment	10.39L	4L	0	-	9T
Other Intangibles, Total	34.28L	22.05L	23.63L	24.87L	25.89L
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	25.62L	25.96L	36.38L	33.19L	37.44L
Total Assets	99.82L	81.15L	65.19L	73.44L	79.48L
Liabilities
Accounts Payable, Total	87.03L	1.41Cr	36.34L	43.02L	51.84L
Accrued Expenses, Total	4L	10.21L	18.81L	17.81L	46.22L
Short-term Borrowings	59.66L	60.54L	1.76Cr	2Cr	2.56Cr
Current Portion of Long-Term Debt	-	-	-	-	81.31L
Current Portion of Leases	6L	4L	44T	42T	44T
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	17.36L	11.27L	36.91L	2L	5L
Total Current Liabilities	1.74Cr	2.27Cr	2.69Cr	2.63Cr	4.41Cr
Long-Term Debt	5.07Cr	4.37Cr	5.33Cr	6.19Cr	5.21Cr
Long-Term Leases	4L	-	-	-	-
Other Non Current Liabilities	12.9L	10L	8L	8L	8L
Total Liabilities	6.99Cr	6.74Cr	8.1Cr	8.91Cr	9.69Cr
Common Stock, Total	33Cr	33Cr	33Cr	33Cr	33Cr
Additional Paid In Capital	5.53Cr	5.5Cr	5.42Cr	5.37Cr	5.39Cr
Retained Earnings	-44Cr	-45Cr	-46Cr	-47Cr	-48Cr
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	-5.99Cr	-5.93Cr	-7.45Cr	-8.17Cr	-8.9Cr
Total Equity	-5.99Cr	-5.93Cr	-7.45Cr	-8.17Cr	-8.9Cr
Total Liabilities And Equity	99.82L	81.15L	65.19L	73.44L	79.48L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25Cr	27Cr	27Cr	28Cr	32Cr
ECS Total Common Shares Outstanding	24Cr	27Cr	27Cr	28Cr	29Cr
Book Value / Share	-0.25	-0.22	-0.27	-0.29	-0.31
Tangible Book Value	-6.33Cr	-6.15Cr	-7.68Cr	-8.42Cr	-9.16Cr
Tangible Book Value Per Share	-0.26	-0.23	-0.28	-0.3	-0.32
Total Debt	5.77Cr	5.02Cr	7.1Cr	8.2Cr	8.59Cr
Net Debt	5.77Cr	5.02Cr	7.09Cr	8.19Cr	8.58Cr
Account Code - Inventory Valuation	-	3	3	3	3
Inventories - Others	24.53L	23.71L	3L	10L	4L
Machinery, Total	4L	3L	3L	-	-
Full Time Employees	22	19	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-2.48Cr	-36.1L	-1.67Cr	-76.35L	-77.67L
Depreciation & Amortization - CF	8L	6L	4L	-	-
Amortization of Goodwill and Intangible Assets - (CF)	3L	4L	3L	3L	4L
Depreciation & Amortization, Total	11.06L	10.07L	7L	3L	4L
Amortization of Deferred Charges, Total - (CF)	3L	3L	2L	-	-
Asset Writedown & Restructuring Costs	-	12.78L	10.29L	-	2L
Stock-Based Compensation (CF)	26.22L	23.92L	12.49L	3L	5L
Other Operating Activities, Total	80.74L	-96.43L	1.03Cr	30.68L	26.57L
Change In Inventories	-72T	-8T	-	-4L	1L
Change In Accounts Payable	39.46L	46.7L	5L	6L	9L
Change in Unearned Revenues	-	-	-	-	-
Change In Deferred Taxes	-4T	-1L	1L	10T	-2T
Change in Other Net Operating Assets	8L	2L	-1T	-2L	-6L
Cash from Operations	-80.24L	-35.41L	-26.13L	-38.86L	-36.61L
Capital Expenditure	-	-	-	-	-9T
Sale (Purchase) of Intangible assets	-9L	-4L	-4L	-5L	-7L
Other Investing Activities, Total	44T	-23T	-68T	95T	47T
Cash from Investing	-8L	-5L	-5L	-4L	-6L
Short Term Debt Issued, Total	60.8L	4L	-	43.78L	43.17L
Total Debt Issued	60.8L	4L	-	43.78L	43.17L
Short Term Debt Repaid, Total	-1L	-4L	-	-	-
Long-Term Debt Repaid, Total	-8L	-6L	-4L	-	-
Total Debt Repaid	-9L	-10L	-4L	-	-
Issuance of Common Stock	40.17L	15.18L	2L	-	-
Other Financing Activities, Total	-4L	30.98L	33.28L	-19T	-
Cash from Financing	88.07L	40.63L	30.94L	43.59L	43.17L
Foreign Exchange Rate Adjustments	-31T	-15T	-	-2T	2T
Net Change in Cash	-81T	34T	-35T	94T	9T
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	9T	11T	-15T	-14T	14T
Levered Free Cash Flow	-85.76L	6L	27.49L	-53.42L	-15.63L
Unlevered Free Cash Flow	-84.38L	13.23L	36.79L	-33.95L	10.62L
Change In Net Working Capital	13.26L	-55.2L	-53.98L	7L	-39.28L
Net Debt Issued / Repaid	52.09L	-6L	-4L	43.78L	43.17L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-96.32	-78.98	-44.23	-41.34	-40.13
Return on Total Capital	805.1	127.38	257.46	4.46T	216.91
Return On Equity %	49.66	6.06	25.03	9.78	9.1
Return on Common Equity	49.66	6.06	25.03	9.78	9.1
Short Term Liquidity
Current Ratio	0.17	0.13	0.02	0.06	0.04
Quick Ratio	0.02	0.02	0	0.01	0.02
Operating Cash Flow to Current Liabilities	-0.46	-0.16	-0.1	-0.15	-0.08
Long Term Solvency
Total Debt/Equity	-96.44	-84.67	-95.27	-100.29	-96.56
Total Debt / Total Capital	-2.71T	-552.16	-2.01T	34.88T	-2.8T
LT Debt/Equity	-85.42	-73.72	-71.57	-75.77	-58.56
Long-Term Debt / Total Capital	-2.4T	-480.75	-1.51T	26.35T	-1.7T
Total Liabilities / Total Assets	699.78	830.51	1.24T	1.21T	1.22T
EBIT / Interest Expense	-22.77	-6.98	-2.87	-1.48	-1.17
EBITDA / Interest Expense	-21.19	-6.37	-2.47	-1.36	-1.07
(EBITDA - Capex) / Interest Expense	-21.19	-6.37	-2.47	-1.36	-1.07
Total Debt / EBITDA	-3.89	-4.81	-15.9	-19.28	-19.18
Net Debt / EBITDA	-3.89	-4.81	-15.9	-19.25	-19.15
Total Debt / (EBITDA - Capex)	-3.89	-4.81	-15.9	-19.28	-19.14
Net Debt / (EBITDA - Capex)	-3.89	-4.81	-15.9	-19.25	-19.12
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	9.27	-29.34	-56.02	-11.82	5.34
EBITA, 1 Yr. Growth %	9.2	-29.21	-55.72	-13.01	5.34
EBIT, 1 Yr. Growth %	9.41	-28.27	-54.71	-11.16	6.72
Earnings From Cont. Operations, 1 Yr. Growth %	-1.11T	-85.43	363.74	-54.39	1.73
Net Income, 1 Yr. Growth %	-1.11T	-85.43	363.74	-54.39	1.73
Normalized Net Income, 1 Yr. Growth %	29.09	-19.26	-32.31	13.02	30.46
Diluted EPS Before Extra, 1 Yr. Growth %	-1.02T	-86.84	337.08	-55.49	-1.32
Inventory, 1 Yr. Growth %	320.03	-3.34	-87.35	232	-56.33
Net Property, Plant and Equip., 1 Yr. Growth %	-28.74	-59	-100	-	-
Total Assets, 1 Yr. Growth %	-6.76	-18.7	-19.67	11.87	8.22
Tangible Book Value, 1 Yr. Growth %	47.92	-2.86	24.97	9.61	8.7
Common Equity, 1 Yr. Growth %	50.07	-0.98	25.63	9.75	8.84
Cash From Operations, 1 Yr. Growth %	82.32	-55.87	-28.02	54.7	-5.79
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-	-106.93	-128.94	774.92	-70.74
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-115.68	-141.91	-754.46	-131.28
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-12.13	-44.25	-37.73	-3.62
EBITA, 2 Yr. CAGR %	-	-12.08	-44.02	-37.94	-4.28
EBIT, 2 Yr. CAGR %	-	-11.41	-43.01	-36.57	-2.63
Earnings From Cont. Operations, 2 Yr. CAGR %	-	21.03	-17.79	45.43	-31.89
Net Income, 2 Yr. CAGR %	-	21.03	-17.79	45.43	-31.89
Normalized Net Income, 2 Yr. CAGR %	-	2.09	-27.62	-12.53	21.43
Diluted EPS Before Extra, 2 Yr. CAGR %	-	10.22	-22.51	39.48	-33.72
Inventory, 2 Yr. CAGR %	-	101.49	-65.03	-35.19	20.42
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-45.95	-	-	-
Total Assets, 2 Yr. CAGR %	-	-12.94	-19.19	-4.87	10.03
Tangible Book Value, 2 Yr. CAGR %	-	19.87	10.18	17.04	9.16
Common Equity, 2 Yr. CAGR %	-	21.9	11.53	17.42	9.29
Cash From Operations, 2 Yr. CAGR %	-	-10.3	-42.93	3.47	20.72
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-43.64	-25.01	60
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-33.97	-37.81	43.07
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-30.23	-35.05	-25.8
EBITA, 3 Yr. CAGR %	-	-	-30.05	-35.16	-25.97
EBIT, 3 Yr. CAGR %	-	-	-29.17	-33.92	-24.56
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	89.39	-32.45	29.1
Net Income, 3 Yr. CAGR %	-	-	89.39	-32.45	29.1
Normalized Net Income, 3 Yr. CAGR %	-	-	-12.22	-16.03	-0.06
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	76.99	-35.58	24.29
Inventory, 3 Yr. CAGR %	-	-	-19.91	-25.95	-43.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-	-72.36
Total Assets, 3 Yr. CAGR %	-	-	-15.24	-9.72	-0.69
Tangible Book Value, 3 Yr. CAGR %	-	-	21.55	9.99	14.19
Common Equity, 3 Yr. CAGR %	-	-	23.13	10.93	14.49
Cash From Operations, 3 Yr. CAGR %	-	-	-15.95	-21.47	0.28
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-14.85	-45.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-26.18	-50.54
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	-20.61
EBITA, 5 Yr. CAGR %	-	-	-	-	-20.7
EBIT, 5 Yr. CAGR %	-	-	-	-	-19.55
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	25.81
Net Income, 5 Yr. CAGR %	-	-	-	-	25.81
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-0.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	19.48
Inventory, 5 Yr. CAGR %	-	-	-	-	-5.72
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-63.85
Total Assets, 5 Yr. CAGR %	-	-	-	-	-5.78
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	16.43
Common Equity, 5 Yr. CAGR %	-	-	-	-	17.4
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-3.62
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-